These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28812984)

  • 1. Modelling the effects of quinidine, disopyramide, and E-4031 on short QT syndrome variant 3 in the human ventricles.
    Luo C; Wang K; Zhang H
    Physiol Meas; 2017 Sep; 38(10):1859-1873. PubMed ID: 28812984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.
    Luo C; Wang K; Zhang H
    PLoS One; 2017; 12(6):e0179515. PubMed ID: 28632743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study.
    Luo C; Wang K; Zhang H
    Biomed Eng Online; 2017 Jun; 16(1):69. PubMed ID: 28592292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proarrhythmia in KCNJ2-linked short QT syndrome: insights from modelling.
    Adeniran I; El Harchi A; Hancox JC; Zhang H
    Cardiovasc Res; 2012 Apr; 94(1):66-76. PubMed ID: 22308236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the effects of chloroquine on
    Luo C; Wang K; Zhang H
    Oncotarget; 2017 Dec; 8(63):106511-106526. PubMed ID: 29290967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atria.
    Whittaker DG; Ni H; El Harchi A; Hancox JC; Zhang H
    PLoS Comput Biol; 2017 Jun; 13(6):e1005593. PubMed ID: 28609477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapeutic Effects of Quinidine on Short QT Syndrome by Using Purkinje-Ventricle Model: A Simulation Study.
    Luo C; Whittaker DG; Liu T; Wang K; Li Y; He Y; Zhang H
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():2856-2859. PubMed ID: 31946488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Analysis of the Action of Chloroquine on Short QT Syndrome Variant 1 and Variant 3 in Human Ventricles.
    Luo C; Wang K; Liu T; Zhang H
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():5462-5465. PubMed ID: 30441573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Analysis of the Mode of Action of Disopyramide and Quinidine on hERG-Linked Short QT Syndrome in Human Ventricles.
    Whittaker DG; Ni H; Benson AP; Hancox JC; Zhang H
    Front Physiol; 2017; 8():759. PubMed ID: 29085299
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Whittaker DG; Hancox JC; Zhang H
    Front Physiol; 2018; 9():1888. PubMed ID: 30687112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibility.
    Odening KE; Bodi I; Franke G; Rieke R; Ryan de Medeiros A; Perez-Feliz S; Fürniss H; Mettke L; Michaelides K; Lang CN; Steinfurt J; Pantulu ND; Ziupa D; Menza M; Zehender M; Bugger H; Peyronnet R; Behrends JC; Doleschall Z; Zur Hausen A; Bode C; Jolivet G; Brunner M
    Eur Heart J; 2019 Mar; 40(10):842-853. PubMed ID: 30496390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the Effects of the Short QT Syndrome D172N Kir2.1 Mutation on Ventricular Action Potential Profile Using Dynamic Clamp.
    Du C; Rasmusson RL; Bett GC; Franks B; Zhang H; Hancox JC
    Front Pharmacol; 2021; 12():794620. PubMed ID: 35115940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine blocks a mutant Kir2.1 channel responsible for short QT syndrome and normalizes repolarization properties in silico.
    Lopez-Izquierdo A; Ponce-Balbuena D; Ferrer T; Sachse FB; Tristani-Firouzi M; Sanchez-Chapula JA
    Cell Physiol Biochem; 2009; 24(3-4):153-60. PubMed ID: 19710529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repolarisation and vulnerability to re-entry in the human heart with short QT syndrome arising from KCNQ1 mutation--a simulation study.
    Zhang H; Kharche S; Holden AV; Hancox JC
    Prog Biophys Mol Biol; 2008; 96(1-3):112-31. PubMed ID: 17905416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action potential clamp and pharmacology of the variant 1 Short QT Syndrome T618I hERG K⁺ channel.
    El Harchi A; Melgari D; Zhang YH; Zhang H; Hancox JC
    PLoS One; 2012; 7(12):e52451. PubMed ID: 23300672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene.
    Priori SG; Pandit SV; Rivolta I; Berenfeld O; Ronchetti E; Dhamoon A; Napolitano C; Anumonwo J; di Barletta MR; Gudapakkam S; Bosi G; Stramba-Badiale M; Jalife J
    Circ Res; 2005 Apr; 96(7):800-7. PubMed ID: 15761194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome: a pilot study.
    Schimpf R; Veltmann C; Giustetto C; Gaita F; Borggrefe M; Wolpert C
    J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1157-60. PubMed ID: 17711440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased vulnerability of human ventricle to re-entrant excitation in hERG-linked variant 1 short QT syndrome.
    Adeniran I; McPate MJ; Witchel HJ; Hancox JC; Zhang H
    PLoS Comput Biol; 2011 Dec; 7(12):e1002313. PubMed ID: 22194679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial proarrhythmia due to increased inward rectifier current (I(K1)) arising from KCNJ2 mutation--a simulation study.
    Kharche S; Garratt CJ; Boyett MR; Inada S; Holden AV; Hancox JC; Zhang H
    Prog Biophys Mol Biol; 2008; 98(2-3):186-97. PubMed ID: 19041665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.